- Home
- /
- Drugs
- /
- T
- /
- Trientine hydrochloride
- /
- Trientine hydrochloride TRIENTINE HYDROCHLORIDE 250 mg/1 Zydus Lifesciences Limited
Trientine hydrochloride
- Trientine hydrochloride TRIENTINE HYDROCHLORIDE 250 mg/1 MSN LABORATORIES PRIVATE LIMITED
- Syprine TRIENTINE HYDROCHLORIDE 250 mg/1 Bausch Health US LLC
- TRIENTINE HYDROCHLORIDE TRIENTINE HYDROCHLORIDE 250 mg/1 Camber Pharmaceuticals, Inc.
- TRIENTINE HYDROCHLORIDE TRIENTINE HYDROCHLORIDE 250 mg/1 Lannett Company Inc.
- Trientine Hydrochloride TRIENTINE HYDROCHLORIDE 250 mg/1 Oceanside Pharmaceutials
- Trientine Hydrochloride TRIENTINE HYDROCHLORIDE 250 mg/1 Navinta LLC
- Trientine Hydrochloride TRIENTINE HYDROCHLORIDE 250 mg/1 Rising Pharma Holdings, Inc.
- Trientine Hydrochloride TRIENTINE HYDROCHLORIDE 250 mg/1 Par Pharmaceutical, Inc.
- Trientine hydrochloride TRIENTINE HYDROCHLORIDE 250 mg/1 Rising Pharmaceuticals, Inc.
- Trientine hydrochloride TRIENTINE HYDROCHLORIDE 250 mg/1 Zydus Pharmaceuticals USA Inc.
- Trientine hydrochloride TRIENTINE HYDROCHLORIDE 250 mg/1 Zydus Lifesciences Limited
- Trientine Hydrochloride TRIENTINE HYDROCHLORIDE 250 mg/1 Dr.Reddys Laboratories Inc
- Trientine Hydrochloride TRIENTINE HYDROCHLORIDE 250 mg/1 Actavis Pharma, Inc.
- Trientine Hydrochloride TRIENTINE HYDROCHLORIDE 250 mg/1 Rising Pharma Holdings, Inc.
Summary of product characteristics
Effective Time
20221017
Version
3
Spl Product Data Elements
Trientine hydrochloride Trientine hydrochloride TRIENTINE HYDROCHLORIDE TRIENTINE FERRIC OXIDE RED FERRIC OXIDE YELLOW FERROSOFERRIC OXIDE GELATIN POTASSIUM HYDROXIDE PROPYLENE GLYCOL SHELLAC STEARIC ACID TITANIUM DIOXIDE WATER light brown cap white body 1203
Application Number
ANDA211554
Brand Name
Trientine hydrochloride
Generic Name
Trientine hydrochloride
Product Ndc
70771-1438
Product Type
HUMAN PRESCRIPTION DRUG
Route
ORAL
Package Label Principal Display Panel
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL NDC 70771-1438-1 Trientine Hydrochloride Capsules, USP 250 mg 100 Capsules Rx only image
Drug section
Learning Zones
The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.
Disclaimer
The drug Prescribing Information (PI), including indications, contra-indications, interactions, etc, has been developed using the U.S. Food & Drug Administration (FDA) as a source (www.fda.gov).
Medthority offers the whole library of PI documents from the FDA. Medthority will not be held liable for explicit or implicit errors, or missing data.
Drugs appearing in this section are approved by the FDA. For regions outside of the United States, this content is for informational purposes only and may not be aligned with local regulatory approvals or guidance.